8-60222436-G-A

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_Strong BP6_Moderate BA1

The NM_004056.6(CA8):c.738+213C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.851 in 152,226 control chromosomes in the GnomAD database, including 55,465 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

• Frequency: Genomes: 𝑓 0.85 (55465 hom., cov: 33)
• Consequence: CA8 NM_004056.6 intron
• Clinical Significance: Benign criteria provided, single submitter B:1
• Conservation: PhyloP100: 0.569

Genes affected

CA8 (HGNC:1382): (carbonic anhydrase 8) The protein encoded by this gene was initially named CA-related protein because of sequence similarity to other known carbonic anhydrase genes. However, the gene product lacks carbonic anhydrase activity (i.e., the reversible hydration of carbon dioxide). The gene product continues to carry a carbonic anhydrase designation based on clear sequence identity to other members of the carbonic anhydrase gene family. The absence of CA8 gene transcription in the cerebellum of the lurcher mutant in mice with a neurologic defect suggests an important role for this acatalytic form. Mutations in this gene are associated with cerebellar ataxia, mental retardation, and dysequilibrium syndrome 3 (CMARQ3). Polymorphisms in this gene are associated with osteoporosis, and overexpression of this gene in osteosarcoma cells suggests an oncogenic role. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2016]

ACMG classification

Verdict is Benign. Variant got -14 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.87).
• BP6: Variant 8-60222436-G-A is Benign according to our data. Variant chr8-60222436-G-A is described in ClinVar as [Benign]. Clinvar id is 1271120.Status of the report is criteria_provided_single_submitter, 1 stars.
• BA1: GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.919 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	UniProt
CA8	NM_004056.6	c.738+213C>T		intron_variant		ENST00000317995.5

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Appris	UniProt
CA8	ENST00000317995.5	c.738+213C>T		intron_variant		1	NM_004056.6	P1
CA8	ENST00000524872.5	n.976+213C>T		intron_variant, non_coding_transcript_variant		1

Frequencies

GnomAD3 genomes AF: 0.852 AC: 129522 AN: 152108 Hom.: 55425 Cov.: 33

Gnomad AFR AF: 0.928

Gnomad AMI AF: 0.917

Gnomad AMR AF: 0.859

Gnomad ASJ AF: 0.866

Gnomad EAS AF: 0.745

Gnomad SAS AF: 0.778

Gnomad FIN AF: 0.796

Gnomad MID AF: 0.791

Gnomad NFE AF: 0.824

Gnomad OTH AF: 0.849

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.851 AC: 129617 AN: 152226 Hom.: 55465 Cov.: 33 AF XY: 0.848 AC XY: 63108 AN XY: 74418

Gnomad4 AFR AF: 0.927

Gnomad4 AMR AF: 0.859

Gnomad4 ASJ AF: 0.866

Gnomad4 EAS AF: 0.745

Gnomad4 SAS AF: 0.778

Gnomad4 FIN AF: 0.796

Gnomad4 NFE AF: 0.824

Gnomad4 OTH AF: 0.851

Alfa AF: 0.831 Hom.: 106592

Bravo AF: 0.862

Asia WGS AF: 0.789 AC: 2746 AN: 3478

ClinVar

Significance: Benign

Submissions summary: Benign:1

Revision: criteria provided, single submitter

Submissions by phenotype

not provided Benign:1

Benign, criteria provided, single submitter

clinical testing

GeneDx

Jun 18, 2021

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.87
Cadd	Benign	6.5
Dann	Benign	0.27

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs6471849; hg19: chr8-61134995;